Views & Analysis | Perspectives on pharma industry issues

Digital

Two female silhouettes in a city office overlook the urban landscape below

How female leadership can benefit industry

Day One Strategy’s founding partners Abigail Stuart and Hannah Mann share the benefits female leadership can bring to industry.

Patients

Maintenance: The underexamined half of the GLP-1 story

GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.

Oncology

pharmaphorum podcast Episode 276, Irina Babina, Concr

Getting predictive technologies to patients, with Concr

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

R&D

Concept of AI overview of patient in clinical trial

How AI simulation could help de-risk obesity and cardiometab...

AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Articles

Pharma news highlights: June

Ed Silverman shares his opinions on some of the latest pharma news, including the controversy over Merck’s new Claritin campaign, the ruling for ‘Obamacare’ and India’s new healthcare policy. There is good reason that many in the pharmaceutical industry look forward to the summer doldrums – the preceding weeks can be crammed...

Articles

Top ten innovators in pharma: Andrew Spong

Our latest top pharma innovator is Andrew Spong, leading digital and social media expert and founder of STweM. We asked you to nominate those who you considered to be a top innovator in pharma. We were delighted with...

Articles

Rare diseases part 2: orphan drugs – a paradigm shift for ma...

Neil Dickinson continues his rare diseases discussion in part two, looking at the marketing by pharma companies of orphan drugs. Back in the early 90s, I remember pitching for a new product launch. It was for a top ten pharma company and the budget...

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Sales & Marketing

The patient communication crisis pharma can no longer ignore

Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.

Digital

How female leadership can benefit industry

Day One Strategy’s founding partners Abigail Stuart and Hannah Mann share the benefits female leadership can bring to industry.

Digital

Pharma brands face golden opportunity to extend supply chain...

People are ready for technology that verifies authenticity and provides helpful information directly from the medicinal product itself.

Market Access

$100 notes in pill bottle on aquamarine background with spilled pills

How new PBM transparency rules will alter drug pricing

The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.

Market Access